Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page
- ChecktodayChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a minor update to the page template or documentation. This update does not affect the study content or data.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe revision label now reads v3.6.3 where it previously showed v3.6.2. This update reflects a small metadata version change and does not modify the study details.SummaryDifference0.0%

- Check29 days agoChange DetectedNew revision tag v3.6.2 has been added, replacing the previous v3.6.0. This reflects a minor update to the page’s underlying documentation/software version without changing the study content or how the page functions.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study page now states that recruitment has ended and includes new sections to help readers understand and join the study. The Intervention/Treatment heading has been standardized.SummaryDifference0.3%

- Check50 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a newer build of the page content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page's revision tag was updated to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.